A 13-year-old girl was referred because of progressive abdominal pain caused by ovarian torsion and giant ovarian cysts. Secondary sexual characteristics were absent. Hormone analysis revealed markedly elevated serum levels of progesterone and 17-hydroxyprogesterone in combination with very low peripheral concentrations of C19 steroids (dehydroepiandrosterone and androstenedione) and estrogens. Serum concentrations of FSH and LH exceeded the upper limit of normal levels in adult women. The patient's 16-year-old 46,XY sibling showed a female phenotype with similar hormonal disturbances. Both siblings were found to be compound heterozygotes for two mutations in the CYP17 gene: an R347C mutation in one allele and a 25-base pair deletion in exon 1 in the other. The resulting block in 17,20-lyase activity caused an inability to synthesize androgens and estrogens, and increased levels of gonadotrophins due to a lack of negative feedback. The increased levels of gonadotrophins most likely stimulated growth of the ovarian cysts. The administration of a GnRH antagonist reduced the size of the cysts within a few weeks. At present, the girl is being treated with a combination of a GnRH agonist and hormone replacement therapy.
Introduction
The cytochromes P450 form a family of enzymes which catalyse many oxidative processes. Some distinct P450 enzymes play key roles in steroidogenesis (Speroff et al., 1999; see Figure 1 ). One of the latter enzymes, P450c17, which is encoded by CYP 17, contains both 17b-hydroxylase and 17,20-lyase activities (Miller et al., 1997; Geller et al., 1999; Biason-Lauber et al., 2000) . To date, 20 different missense mutations in the CYP 17 gene have been identi®ed, leading to inactivation of the hydroxylase and/or lyase activities (Van den Akker et al., 2002) . The degree of inactivation is dependent on the type and localization of the mutation in the gene.
In most situations the combined de®ciency occurs, but several cases of isolated 17,20-lyase de®ciency have also been described (Zachmann et al., 1972; Goebelsmann et al., 1976; Van den Akker et al., 2002) . Affected 46,XY individuals are male pseudohermaphrodites with ambiguous or female external genitalia as a result of impairment of testosterone synthesis in the testes (Zachmann et al., 1982; Oei et al., 1995; Katsumata et al., 2001) . One group (Larrea et al., 1983) published a case report about an XX female individual with hypergonadotrophic hypogonadism due to 17,20-lyase de®-ciency. These authors described clinical features of primary amenorrhoea and sexual infantilism in combination with elevated serum levels of progesterone and 17-hydroxyprogesterone (17-OHP) and anestrogenism. The present report describes a 46,XX child with a female phenotype and enlarged ovarian cysts with elevated gonadotrophins. She had an older 46,XY sibling with a female phenotype who has been described previously (patient 3 in Van den Akker et al., 2002) . In the present report, mutations of the CYP17 gene were ascertained in the 46,XX girl and her mother, and the effects of treatment of the girl with GnRH analogues described.
Case report
A 13-year-old girl in whom menarche and puberty had not yet occurred was referred by her paediatrician for gynaecological investigation because of progressive abdominal pain. Abdominal pelvic ultrasound and magnetic resonance imaging revealed the presence of a cervix, a uterus and multiple ovarian cysts. On physical examination, the patient was found to be a healthy child with a normal 46,XX karyotype and blood pressure 140/80 mmHg. The hymen was normal, so an imperforated hymen and haematocolpus could be excluded. Signs of sexual maturation were absent, as was masculinization. Carpus X-radiographs were consistent with a bone age of 11.5 years. Hormone analysis revealed markedly elevated serum 17-OHP and progesterone levels, in combination with very low levels of androstenedione, dehydroepiandrosterone (DHEA) and sex steroids estradiol (E 2 ) and testosterone (Table I) . LH and FSH levels were elevated for a premenarchal girl, and also exceeded the upper end of the normal level in an adult woman. The basal serum cortisol level was normal, but there appeared to be an insuf®cient response after stimulation by adrenocorticotrophic hormone (ACTH) ( Table II) . Serum concentrations of 17-OHP, progesterone, testosterone, androstenedione and DHEA did not change after ACTH stimulation (data not shown). Thyroid function and serum prolactin were normal. Ovarian tumour markers (CA125, hCG and afetoprotein) were all negative.
The increasing abdominal pain necessitated a diagnostic laparoscopy, whereupon a large number of giant ovarian cysts (diameter ranging from 2±6 cm) with ascites imitating ovarian hyperstimulation syndrome were observed. The enlarged ovaries each measured about 12Q15 cm. Most of the cysts were emptied by puncture, and the double-twisted right ovary was returned. Further exploration revealed a normally sized infantile uterus and normal tubes. Samples of¯uid taken from four cysts contained high levels of progesterone and 17-OHP ( Table III) . The levels of androstenedione, testosterone and E 2 in these¯uid samples were below the normal ranges described by others (diZerega et al., 1983) . Histological examination of the cyst¯uid revealed the presence of granulosa cells. Some oocytes were found in biopsy samples taken from the ovaries, predominantly in the primordial follicles. Following the laparoscopic procedure, the girl experienced temporal relief from her complaints, and hormone replacement therapy was started with a combined contraceptive pill containing 30 mg ethinylestradiol and 150 mg levonorgestrel. However, within a few weeks she suffered again from episodic abdominal pain, and enlarged ovarian cysts were observed using sonography. She was treated with a GnRH antagonist (cetrorelix 0.25 mg s.c., daily) in order to obtain a rapid reduction in cyst size, and this was followed by relief of the complaints. Thereafter, in order to suppress LH and FSH levels permanently and to initiate sexual development, the girl was started on GnRHagonist and hormone replacement therapy, with triptorelin and E 2 (0.1 mg s.c. and 5 mg/kg bodyweight daily respectively). Later, 10.8 mg goserelin s.c. every 3 months was prescribed, instead of the daily triptorelin. During the last year, the patient was found to have normally sized ovaries without cysts, while LH and FSH were each down-regulated and the serum progesterone and 17-OHP levels were reduced, though not normalized (Table I) . Withdrawal bleedings have not yet occurred. At presentÐat about 18 months after her initial complaintsÐthe girl receives 20 mg E 2 /kg bodyweight daily, has developed some secondary signs of puberty, and is still growing.
The index patient's 16-year-old genetically male`sister' had the same hormonal disturbances. At the age of 2 months, this new-born with a female phenotype had bilateral inguinal hernias which contained testes. Prophylactic gonadectomy was performed a few months later. The karyotype was shown to be 46,XY, and she was raised as a girl. Initially, it was thought that she suffered from androgen insensitivity syndrome, but at the age of 10 years, after analysis of the androgen receptor gene, re-evaluation revealed this child to have a 17,20-lyase de®ciency (Van den Akker et al., 2002) . Her blood pressure was 140/80 mmHg. For reason of comparison, hormone levels measured in this patient at the age of 10 years after gonadectomy are included in Table I . The medical history of this case only became known to the gynaecologist following laparoscopy of the index patient. Figure 1 . Schematic representation of steroid biosynthesis, leading to the production of mineralocorticoids, glucocorticoids and sex steroids. 1 indicates the cholesterol side chain cleavage enzyme and 2 indicates the 3b-hydroxysteroid dehydrogenase (3b-HSD). The enzyme coded by the CYP 17 gene has both 17a-hydroxylase and 17,20-lyase activities. Absence of the 17,20-lyase activity, indicated by the broken arrows, leads to the inability to produce dehydroepiandrosterone (DHEA), androstenedione and the sex steroids testosterone and estradiol.
Con®rmation of the enzyme defect
Based on hormone data from the index case and the enzyme de®ciency in her sister, a defective CYP17 gene was expected in the index patient, causing isolated defective 17,20-lyase activity (Figure 1) . In order to con®rm a genetic disorder, DNA from blood lymphocytes from both the index patient and her mother was analysed for mutations in this gene using methods described previously (Van den Akker et al., 2002). The index patient was shown to be compound heterozygote for the same combination of two mutations in the CYP17 gene found earlier in her sister: a missense R347C (CGT ® TGT) point mutation and a 25-base pair (bp) deletion in exon 1 (nucleotides 204±228 of the coding sequence). The 25 bp deletion was demonstrated in the DNA of the mother, making it likely that the children had inherited the R347C mutation from their father.
Discussion
The present patient and her sister each carried the mutation R347C in the paternal allele of CYP17 and a frameshift mutation in the maternal allele. R347 is located in the redox partner interaction domain of the enzyme and contributes to the positive charges on the proximal surface of P450c17. A normal function of the redox partner protein interaction is necessary for 17,20-lyase activity. Hence, a mutation in R347 selectively impairs the 17,20-lyase activity by absence of the positively charged arginine and is not critical for 17a-hydroxylase activity (Auchus et al., 2000) . Others (Van den Akker et al., 2002) explained the more deleterious effect of the R347C mutation as compared to the R347H mutation described previously (Geller et al., 1999) on the basis of a possibility to form disulphide bridges in the R347C protein. The deletion of 25 base pairs in exon 1 of the other allele results in a premature stop codon and, as a consequence, a complete loss of enzyme activity. The steroid levels in the samples of cyst¯uid re¯ected the enzyme defect: relatively normal levels of progesterone and 17-OHP were accompanied by strongly suppressed levels of androstenedione, testosterone and estradiol. The ratio between the sum of the mean concentrations of these three hormones on the one hand and 17OHP on the other was at least 500-fold lower compared with data reported elsewhere (diZerega et al., 1983) .
The majority of cases with either combined or isolated 17a-hydroxylase/17,20-lyase de®ciencies described so far have been male pseudohermaphrodites with ambiguous or female external genitalia (Zachmann et al., 1982; Oei et al., 1995) . One group (Biglieri et al., 1966) were the ®rst to describe 17a-hydroxylase de®ciency in a female individual with primary amenorrhoea, and a case study was subsequently reported (Mallin, 1969) concerning two sisters with amenorrhoea, hypokalaemia, hypertension and cystic ovaries, based on 17a-hydroxylase de®ciency. An absence of the enzyme led to a de®cient sex steroid synthesis on the one hand and a reduced cortisol synthesis on the other hand. Another group (Pertzeran et al., 1981) described a 15-year-old girl with an absence of sexual development, polycystic ovaries and hypertension due to 17a-hydroxylase de®ciency. Finally, a report was made about a female individual with hypergonadotrophic hypogonadism due to 17,20-lyase de®ciency (Larrea et al., 1983) , while others (Pellicer et al., 1991) described a female patient with 17,20-lyase de®ciency in combination with hypogonadotrophic hypogonadism.
The hyperstimulated ovaries with cysts in the present patient presumably resulted from elevated FSH and LH levels secondary to the lack of estrogens. These high levels of FSH and LH may have caused the stimulation of growth of follicles in the ovaries and therefore the increased serum levels of progesterone and 17-OHP. Initially, the girl was treated with an oral contraceptive to suppress gonadotrophins, but within a few weeks after the laparoscopy she had suffered again from episodic abdominal pain caused by enlarged ovarian cysts, probably because the estrogen dose was inadequate to suppress the gonadotrophin levels. As a higher estrogen dose might have created a risk to the girl's ®nal body height, she was further treated with a GnRH antagonist in order to suppress the cysts rapidly. Later, treatment was switched to a GnRH agonist in combination with estrogens in order to initiate sexual development. After suppression of the gonadotrophins with the GnRH-agonist, concentrations of progesterone and 17-OHP were each reduced to levels comparable with those in the gonadectomized sister. If the girl had not developed enlarged ovaries, she would most likely have been referred some years later with primary amenorrhoea and an absence of any signs of puberty.
In the present patient, the synthesis of cortisol was not (or was only slightly) impaired under basal circumstances, because of residual 17a-hydroxylase activity. An ACTH stimulation test showed a low to normal basal level of cortisol, which did not respond to ACTH (Table II) , and this was suggestive of a partial 17a-hydroxylase de®ciency. It is questionable whether this could be regarded as a mild form of glucocorticoid insuf®ciency, as the adrenal glands should be able to produce corticosterone, which also has glucocorticoid activity.
Questions remain about the girl's chances of future pregnancy, however. Based on the results of a previous study (Schoot et al., 1994) , it was apparent that ovarian stimulation with recombinant FSH in hypogonadotrophic women resulted in ovarian follicle development to the pre-ovulatory stage, with no or only a minor increase in estradiol concentrations. Others (Rabinovici et al., 1989; Pellicer et al., 1991) described successful IVF after oocyte retrieval from women with combined 17a-hydroxylase/17,20-lyase and 17,20-lyase de®-ciency respectively. Hence, it cannot be taken for granted that a lack of endogenous estrogen production automatically leads to a failure of follicular maturation. An important point here is how to deal with the ethical dilemmas related to the inheritance of a disease in case of reproduction.
In conclusion, the present case report illustrates the clinical expression of an identical rare genetic disorder in a female and a male proband. Both were compound heterozygotes for the same mutations in the CYP17, gene resulting in a 17,20-lyase de®ciency, and as a consequence the circulating levels of sex steroids were either absent or extremely low. Although for both children this had medical and emotional implications, the clinical picture of the mutations was completely different. The boy was reared as a girl based on his female phenotype, whereas in the girl the increased gonadotrophin levels gave rise to formation of ovarian cysts, which necessitated permanent suppression of pituitary secretion of LH and FSH. At present, these patients with GnRH analogues can be treated and their ovaries preserved.
